JFNIX
Price
$68.63
Change
+$0.92 (+1.36%)
Updated
Aug 15 closing price
Net Assets
4.28B
LHCSX
Price
$19.12
Change
+$0.12 (+0.63%)
Updated
Aug 15 closing price
Net Assets
7.55M
Interact to see
Advertisement

JFNIX vs LHCSX

Header iconJFNIX vs LHCSX Comparison
Open Charts JFNIX vs LHCSXBanner chart's image
Janus Henderson Global Life Sciences I
Price$68.63
Change+$0.92 (+1.36%)
VolumeN/A
Net Assets4.28B
Lord Abbett Health Care R4
Price$19.12
Change+$0.12 (+0.63%)
VolumeN/A
Net Assets7.55M
JFNIX vs LHCSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JFNIX vs. LHCSX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and LHCSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.29B vs. LHCSX (7.55M). JFNIX pays higher dividends than LHCSX: JFNIX (0.41) vs LHCSX (0.34). JFNIX was incepted earlier than LHCSX: JFNIX (16 years) vs LHCSX (6 years). LHCSX (3.34) is less costly to investors than JFNIX (0.77). LHCSX is a more actively managed with annual turnover of: 88.00 vs. JFNIX (35.00). LHCSX has a lower initial minimum investment than JFNIX: LHCSX (0) vs JFNIX (2500). LHCSX annual gain was more profitable for investors over the last year : -4.97 vs. JFNIX (-14.21). JFNIX return over 5 years is better than : 5.30 vs. LHCSX (4.40).
JFNIXLHCSXJFNIX / LHCSX
Total Expense Ratio0.771.0375%
Annual Report Gross Expense Ratio0.773.3423%
Fund Existence16 years6 years-
Gain YTD0.897-0.157-572%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.29B7.55M56,770%
Annual Yield % from dividends0.410.34121%
Returns for 1 year-14.21-4.97286%
Returns for 3 years6.347.0889%
Returns for 5 years5.304.40121%
Returns for 10 years12.82N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OTCCX22.320.01
+0.04%
MFS Mid Cap Growth C
QABGX23.19-0.02
-0.09%
Federated Hermes MDT Balanced A
REVCX13.46-0.05
-0.37%
Columbia Global Value C
BIALX29.95-0.11
-0.37%
Brown Advisory Global Leaders Investor
TETIX15.00-0.15
-0.99%
RBC Enterprise I